MRSA Survivors Network, the nonprofit and official organization for World MRSA Day has announced the theme for 2010: “The MRSA Epidemic- A Call to Action…
More: continued here
Filed under: MRSA / Drug Resistance on February 27th, 2010 | No Comments »
Investigators at The Methodist Hospital Research Institute in Houston examined for the first time the long-term response to strep throat on a genome-wide level, shedding light on how group A streptococcus interacts with the patient’s immune system and attempts to circumvent it. Results were published in the Proceedings of the National Academy of Sciences (PNAS)…
More: […]
Filed under: MRSA / Drug Resistance on February 26th, 2010 | No Comments »
According to a new study, sepsis and pneumonia, two common conditions caused by hospital-aquired infections like MRSA, killed 48,000 Americans in 2006, and cost the nation over 8 billion dollars to treat…
More: continued here
Filed under: MRSA / Drug Resistance on February 26th, 2010 | No Comments »
Researchers report that they have discovered - and now know how to exploit - an unusual chemical reaction mechanism that allows malaria parasites and many disease-causing bacteria to survive. The research team, from the University of Illinois, also has developed the first potent inhibitor of this chemical reaction. The findings appear in the Proceedings of […]
Filed under: MRSA / Drug Resistance on February 21st, 2010 | No Comments »
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria…
More: continued here
Filed under: MRSA / Drug Resistance on February 11th, 2010 | No Comments »
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda “failed quality testing” because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S…
More: continued here
Filed under: MRSA / Drug Resistance on February 10th, 2010 | No Comments »
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda “failed quality testing” because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S…
More: continued here
Filed under: MRSA / Drug Resistance on February 10th, 2010 | No Comments »
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda “failed quality testing” because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S…
More: continued here
Filed under: MRSA / Drug Resistance on February 10th, 2010 | No Comments »
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda “failed quality testing” because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S…
More: continued here
Filed under: MRSA / Drug Resistance on February 10th, 2010 | No Comments »
CNN reports on efforts to combat hospital-acquired infections, which affect 1.7 million people each year and kill 99,000, while adding $28 billion to the nation’s overall health care bill, according to federal research. “But there are signs of improvement…
More: continued here
Filed under: MRSA / Drug Resistance on January 25th, 2010 | No Comments »